4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder

Details for Australian Patent Application No. 2010212467 (hide)

Owner Dynogen Pharmaceuticals, Inc.

Inventors Cavalla, David; Gristwood, Robert William

Agent Davies Collison Cave

Pub. Number AU-A-2010212467

Parent 2007202664

Filing date 20 August 2010

Wipo publication date 16 September 2010

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

9 September 2010 Complete Application Filed

16 September 2010 Application Open to Public Inspection

  Published as AU-A-2010212467

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212468-Amylin family peptides and methods for making and using them

2010212466-Peptides with the capacity to bind to transforming growth factor beta1 (TGF beta1)